We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
-1.89%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
AUM
$286M
AUM Growth
-$143M
Cap. Flow
-$112M
Cap. Flow %
-39.32%
Top 10 Hldgs %
50.25%
Holding
1,291
New
379
Increased
118
Reduced
110
Closed
598

Sector Composition

Rank Sector Weight
1 Healthcare 24.91%
2 Communication Services 16.31%
3 Financials 12.88%
4 Technology 10.56%
5 Industrials 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCV
601
Virtus Convertible & Income Fund
NCV
$392M
$1K ﹤0.01%
90
NCZ
602
Virtus Convertible & Income Fund II
NCZ
$307M
$1K ﹤0.01%
69
+13
+23% +$280
NLY icon
603
Annaly Capital Management
NLY
$17.5B
$1K ﹤0.01%
50
-330
-87% -$13.2K
OIH icon
604
CALL
VanEck Oil Services ETF
OIH
$1.96B
$1K ﹤0.01%
+4
New +$1.58K
ACH
605
Accendra Health
ACH
$96.1M
$1K ﹤0.01%
180
PCK
606
DELISTED
Pimco California Municipal Income Fund II
PCK
$1K ﹤0.01%
180
PCQ
607
Pimco California Municipal Income Fund
PCQ
$168M
$1K ﹤0.01%
90
PFN
608
PIMCO Income Strategy Fund II
PFN
$707M
$1K ﹤0.01%
135
PGP
609
PIMCO Global StockPLUS & Income Fund
PGP
$102M
$1K ﹤0.01%
90
PNF
610
DELISTED
PIMCO New York Municipal Income Fund
PNF
$1K ﹤0.01%
90
-1,142
-93% -$13.2K
PZC
611
DELISTED
PIMCO California Municipal Income Fund III
PZC
$1K ﹤0.01%
180
PZZA icon
612
CALL
Papa John's
PZZA
$804M
$1K ﹤0.01%
41
-39
-49% -$1.97K
SAR icon
613
Saratoga Investment
SAR
$312M
$1K ﹤0.01%
+90
New +$1.95K
SRPT icon
614
PUT
Sarepta Therapeutics
SRPT
$1.93B
$1K ﹤0.01%
10
TAK icon
615
PUT
Takeda Pharmaceutical
TAK
$55.6B
$1K ﹤0.01%
+60
New +$1.01K
TOVX icon
616
Theriva Biologics
TOVX
$10.6M
$1K ﹤0.01%
9
TR icon
617
Tootsie Roll Industries
TR
$2.95B
$1K ﹤0.01%
+57
New +$1.46K
TTWO icon
618
CALL
Take-Two Interactive
TTWO
$45.4B
$1K ﹤0.01%
+10
New +$1.15K
WHG icon
619
Westwood Holdings Group
WHG
$184M
$1K ﹤0.01%
+45
New +$1.85K
WLKP icon
620
PUT
Westlake Chemical Partners
WLKP
$777M
$1K ﹤0.01%
+53
New +$1.22K
RPT
621
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$1K ﹤0.01%
135
ZYNE
622
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$1K ﹤0.01%
500
-5,500
-92% -$30.1K
NBEV
623
CALL
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$1K ﹤0.01%
+365
New +$1.91K
DISCB
624
DELISTED
Discovery, Inc. Series B Common Stock
DISCB
$1K ﹤0.01%
45
+44
+4,400% +$1.52K
APHA
625
DELISTED
Aphria Inc. Common Shares
APHA
$1K ﹤0.01%
+200
New +$1.58K

Similar funds

FNY Investment Advisers's Q4 2018 Portfolio in Review

As of Q4 2018, FNY Investment Advisers held 1,291 positions worth $286M, down 33% from $428M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

FNY Investment Advisers withdrew a net $112M in Q4 2018, closing 598 positions and reducing 110 holdings. Its most notable exit was Aetna Inc, an estimated $58.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 13% a quarter earlier, followed by Communication Services and Financials.

Against the trend, FNY Investment Advisers opened a new position in Red Hat Inc worth $16.6M.

  • FNY Investment Advisers's largest Q4 2018 buy was Red Hat Inc: 94,676 shares worth $16.6M.
  • FNY Investment Advisers added most to Shire pic in Q4 2018, an estimated $33.7M increase.
  • FNY Investment Advisers's biggest Q4 2018 reduction was Altra Industrial Motion Corp, cutting an estimated $32.1M.
  • FNY Investment Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $58.3M.
  • FNY Investment Advisers's ten largest holdings make up 50% of its $286M portfolio in Q4 2018.
  • FNY Investment Advisers opened 379 new positions and closed 598 in Q4 2018.
  • FNY Investment Advisers's portfolio value fell 33% quarter-over-quarter to $286M.

Based on FNY Investment Advisers's 13F filing for Q4 2018, filed 22 Jan 2019.